"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to MLTX. [ FAQ on what and how to ask] For non-MLTX questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Dr. Jorge Santos da Silva Ph.D.
Headquarter: Dorfstrasse 29, Zug, Switzerland, 6300
Industry: Biotechnology, Investment Track: -, Employees: 130
MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases in dermatology and rheumatology, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.
My Watchlist
